(Washington, DC) – Drug manufacturers and some Members of Congress claim that allowing Medicare to negotiate drug prices would limit funding for research and development. …
(Washington, DC) – Drug manufacturers and some Members of Congress claim that allowing Medicare to negotiate drug prices would limit funding for research and development. …